Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02275039
Title p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST